At a glance
- Originator Merck Frosst
- Class Acetic acids; Antiallergics
- Mechanism of Action Leukotriene inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Respiratory tract disorders
Most Recent Events
- 20 Aug 1996 No-Development-Reported for Respiratory tract disorders in Canada (Unknown route)